Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients-Reference-Cited by-同舟云学术

Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients

Published:2022-06 Issue:3 Volume:20 Page:e217-e226
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Jeyapala Renu,Kamdar Shivani,Olkhov-Mitsel Ekaterina,Zlotta Alexandre,Fleshner Neil,Visakorpi Tapio^ORCID,van der Kwast Theodorus^ORCID,Bapat Bharati^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference38 articles.

1. Clinical variability and molecular heterogeneity in prostate cancer;Shoag;Asian J Androl,2016

2. The diagnosis and treatment of prostate cancer: a review;Litwin;JAMA,2017

3. Spatial genomic heterogeneity within localized, multifocal prostate cancer;Boutros;Nat Genet,2015

4. The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol,2016

5. A prostate cancer "nimbosus": genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies;Chua;Eur Urol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cribriform pattern 4/intraductal carcinoma of the prostate and persistent prostate‐specific antigen after radical prostatectomy;BJUI Compass;2024-05-15

2. Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort;Journal of Clinical Pathology;2024-02-20

3. ‘High proliferative cribriform prostate cancer’ defines a patient subgroup with an inferior prognosis;Histopathology;2023-07-28

4. Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification;Modern Pathology;2022-11